ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK)

HKD 5.36

(-1.83%)

Revenue Summary of ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s latest annual revenue in 2023 was 386 Thousand CNY , down -28.25% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s latest quarterly revenue in 2024 Q2 was 386.29 Thousand HKD , down -0.15% from previous quarter.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported a annual revenue of 538 Thousand CNY in annual revenue 2022, down -89.38% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported a annual revenue of 5.06 Million CNY in annual revenue 2021, down 0.0% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported a quarterly revenue of 386.29 Thousand HKD for 2024 Q2, down -0.15% from previous quarter.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported a quarterly revenue of 324.1 Thousand HKD for 2023 Q4, down -92.2% from previous quarter.

Annual Revenue Chart of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (2023 - 2021)

Historical Annual Revenue of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (2023 - 2021)

Year Revenue Revenue Growth
2023 386 Thousand CNY -28.25%
2022 538 Thousand CNY -89.38%
2021 5.06 Million CNY 0.0%

Peer Revenue Comparison of ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD 99.92%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD 99.993%